389 related articles for article (PubMed ID: 30707602)
21. Aripiprazole for the treatment of irritability associated with autism.
Farmer CA; Aman MG
Expert Opin Pharmacother; 2011 Mar; 12(4):635-40. PubMed ID: 21294670
[TBL] [Abstract][Full Text] [Related]
22. Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response.
Salazar de Pablo G; Pastor Jordá C; Vaquerizo-Serrano J; Moreno C; Cabras A; Arango C; Hernández P; Veenstra-VanderWeele J; Simonoff E; Fusar-Poli P; Santosh P; Cortese S; Parellada M
J Am Acad Child Adolesc Psychiatry; 2023 Feb; 62(2):151-168. PubMed ID: 35470032
[TBL] [Abstract][Full Text] [Related]
23. l -carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial.
Nasiri M; Parmoon Z; Farahmand Y; Moradi A; Farahmand K; Moradi K; Basti FA; Mohammadi MR; Akhondzadeh S
Int Clin Psychopharmacol; 2024 Jul; 39(4):232-239. PubMed ID: 37551601
[TBL] [Abstract][Full Text] [Related]
24. Aripiprazole for the treatment of irritability and aggression in children and adolescents affected by autism spectrum disorders.
Rizzo R; Pavone P
Expert Rev Neurother; 2016 Aug; 16(8):867-74. PubMed ID: 27388494
[TBL] [Abstract][Full Text] [Related]
25. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
Nikoo M; Radnia H; Farokhnia M; Mohammadi MR; Akhondzadeh S
Clin Neuropharmacol; 2015; 38(1):11-7. PubMed ID: 25580916
[TBL] [Abstract][Full Text] [Related]
26. Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.
Hellings JA; Arnold LE; Han JC
Expert Opin Pharmacother; 2017 Apr; 18(6):581-588. PubMed ID: 28335658
[TBL] [Abstract][Full Text] [Related]
27. A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.
Ghanizadeh A; Moghimi-Sarani E
BMC Psychiatry; 2013 Jul; 13():196. PubMed ID: 23886027
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.
Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y
Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605
[TBL] [Abstract][Full Text] [Related]
29. Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.
Aman MG; Kasper W; Manos G; Mathew S; Marcus R; Owen R; Mankoski R
J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):415-22. PubMed ID: 20973712
[TBL] [Abstract][Full Text] [Related]
30. Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.
Levine SZ; Kodesh A; Goldberg Y; Reichenberg A; Furukawa TA; Kolevzon A; Leucht S
Eur Psychiatry; 2016 Feb; 32():16-20. PubMed ID: 26802979
[TBL] [Abstract][Full Text] [Related]
31. A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder.
Dominick K; Wink LK; McDougle CJ; Erickson CA
J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):397-401. PubMed ID: 26091194
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment.
Choi H; Kim JH; Yang HS; Kim JY; Cortese S; Smith L; Koyanagi A; Dragioti E; Radua J; Fusar-Poli P; Shin JI; Cheon KA; Solmi M
Mol Autism; 2024 Jan; 15(1):7. PubMed ID: 38263251
[TBL] [Abstract][Full Text] [Related]
33. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
[TBL] [Abstract][Full Text] [Related]
34. Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance.
Sugimoto Y; Yamamura K; Takayama T; Fukuta Y; Aoki K; Mikami K; Tomoda A
BMC Psychiatry; 2021 Apr; 21(1):204. PubMed ID: 33888067
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.
Siafis S; Çıray O; Wu H; Schneider-Thoma J; Bighelli I; Krause M; Rodolico A; Ceraso A; Deste G; Huhn M; Fraguas D; San José Cáceres A; Mavridis D; Charman T; Murphy DG; Parellada M; Arango C; Leucht S
Mol Autism; 2022 Mar; 13(1):10. PubMed ID: 35246237
[TBL] [Abstract][Full Text] [Related]
36. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
[TBL] [Abstract][Full Text] [Related]
37. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.
Marcus RN; Owen R; Kamen L; Manos G; McQuade RD; Carson WH; Aman MG
J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1110-1119. PubMed ID: 19797985
[TBL] [Abstract][Full Text] [Related]
38. Psychopharmacological interventions in autism spectrum disorder.
Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG
JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
